Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.

Fraune C, Lange S, Krebs C, Hölzel A, Baucke J, Divac N, Schwedhelm E, Streichert T, Velden J, Garrelds IM, Danser AH, Frenay AR, van Goor H, Jankowski V, Stahl R, Nguyen G, Wenzel UO.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F1037-48. doi: 10.1152/ajprenal.00672.2011. Epub 2012 Jul 11.

PMID:
22791343
2.
3.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
4.

[Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].

Horký K.

Vnitr Lek. 2010 Feb;56(2):120-6. Review. Czech.

PMID:
20329582
5.

Renin inhibition in hypertension.

Gradman AH, Kad R.

J Am Coll Cardiol. 2008 Feb 5;51(5):519-28. doi: 10.1016/j.jacc.2007.10.027. Review.

6.

Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.

Angeli F, Reboldi G, Mazzotta G, Poltronieri C, Garofoli M, Ramundo E, Biadetti A, Verdecchia P.

Curr Drug Saf. 2012 Feb;7(1):76-85. Review.

PMID:
22663961
7.

Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.

Dalla Vestra M, Simioni N, Masiero A.

Minerva Endocrinol. 2009 Dec;34(4):333-8. Review.

PMID:
20046162
8.

Aliskiren, the future of renin-angiotensin system blockade?

Uresin Y, Mehtar Bozkurt M, Sabirli S, Ozunal ZG.

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):835-49. Review.

PMID:
17867914
9.

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.

Yarows SA.

Expert Rev Cardiovasc Ther. 2010 Jan;8(1):19-33. Review.

PMID:
20030022
10.

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Review.

PMID:
19900020
11.

Direct renin inhibition--a promising strategy for renal protection?

Lizakowski S, Tylicki L, Rutkowski B.

Med Sci Monit. 2013 Jun 12;19:451-7. doi: 10.12659/MSM.883949. Review.

12.

New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.

Feldman DL.

Hypertens Res. 2010 Apr;33(4):279-87. doi: 10.1038/hr.2010.19. Epub 2010 Mar 5. Review.

PMID:
20203685
13.

Potential benefits of aliskiren beyond blood pressure reduction.

Weintraub HS, Tran H, Schwartzbard A.

Cardiol Rev. 2011 Mar-Apr;19(2):90-4. doi: 10.1097/CRD.0b013e318204d9ae. Review.

PMID:
21285669
14.

Aliskiren: the first direct renin inhibitor available for clinical use.

Morganti A, Lonati C.

J Nephrol. 2011 Sep-Oct;24(5):541-9. doi: 10.5301/jn.5000008. Review.

PMID:
21786226
15.

Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.

Buczko W, Hermanowicz JM.

Pharmacol Rep. 2008 Sep-Oct;60(5):623-31. Review.

16.

Update on role of direct renin inhibitor in diabetic kidney disease.

Dhakarwal P, Agrawal V, Kumar A, Goli KM, Agrawal V.

Ren Fail. 2014 Jul;36(6):963-9. doi: 10.3109/0886022X.2014.900425. Epub 2014 Mar 31. Review.

PMID:
24678880
17.

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.

Bomback AS, Toto R.

Am J Hypertens. 2009 Oct;22(10):1032-40. doi: 10.1038/ajh.2009.138. Epub 2009 Aug 6. Review.

PMID:
19661925
18.

Renin inhibition with aliskiren: where are we now, and where are we going?

Azizi M, Webb R, Nussberger J, Hollenberg NK.

J Hypertens. 2006 Feb;24(2):243-56. Review.

PMID:
16508564
19.

Renin inhibitors in chronic heart failure: the Aliskiren Observation of Heart Failure Treatment study in context.

Krum H, Maggioni A.

Clin Cardiol. 2010 Sep;33(9):536-41. doi: 10.1002/clc.20828. Review.

20.

Aliskiren in the treatment of hypertension and organ damage.

Riccioni G.

Cardiovasc Ther. 2011 Feb;29(1):77-87. doi: 10.1111/j.1755-5922.2010.00230.x. Epub 2010 Nov 25. Review.

PMID:
21106033

Supplemental Content

Support Center